The Discounted Cash Flow (DCF) valuation of Shanghai Pharmaceuticals Holding Co Ltd (601607.SS) is 10.65 CNY. With the latest stock price at 16.26 CNY, the upside of Shanghai Pharmaceuticals Holding Co Ltd based on DCF is -34.5%.
Based on the latest price of 16.26 CNY and our DCF valuation, Shanghai Pharmaceuticals Holding Co Ltd (601607.SS) is a sell. selling 601607.SS stocks now will result in a potential gain of 34.5%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 6.8% | 6.1% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 4.09 - 26.66 | 10.65 |
| Upside | -74.9% - 63.9% | -34.5% |